Page last updated: 2024-10-30

memantine and Intellectual Disability

memantine has been researched along with Intellectual Disability in 1 studies

Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)

Research Excerpts

ExcerptRelevanceReference
"To investigate the use of antipsychotics, benzodiazepine derivatives, and drugs recommended for dementia treatment (anticholinesterases [AChEIs] and memantine) among people with ID and dementia."3.85Use of antipsychotics, benzodiazepine derivatives, and dementia medication among older people with intellectual disability and/or autism spectrum disorder and dementia. ( Ahlström, G; Axmon, A; Kristensson, J; Midlöv, P, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Axmon, A1
Kristensson, J1
Ahlström, G1
Midlöv, P1

Other Studies

1 other study available for memantine and Intellectual Disability

ArticleYear
Use of antipsychotics, benzodiazepine derivatives, and dementia medication among older people with intellectual disability and/or autism spectrum disorder and dementia.
    Research in developmental disabilities, 2017, Volume: 62

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Autism Spectrum Disorder; Benzodiazepines; Cholineste

2017